Skip to content

clinical study of cervical manipulation for cervicogenic dizziness

clinical study of cervical manipulation for cervicogenic vertigo/dizziness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ONRC-13003186
Enrollment
Unknown
Registered
2013-01-15
Start date
2013-04-22
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervicogenic vertigo/dizziness

Interventions

intervention group:cervical manipulation

Sponsors

Shanghai University of T.C.M
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 60, both male and female; 2. Patients in treatment group should accord with the diagnostic criteria of the main symptom of vertigo or/and dizziness of Cervical spondylosis of vertebral artery typesympathetic cervical spondylopathy as well as neck pain with dizziness; 3. Voluntarily participating the study with signed Informed Consent.

Exclusion criteria

Exclusion criteria: 1. Patients meet the diagnostic criteria of cervical spondylotic radiculopathy and cervical spondylotic myelopathy and severe cervical stenosis; 2. History of patients with spinal surgery and severe spinal trauma; 3. Patients with known unstable congenital deformity of cervical structures,such as basilar impression, cervical fusion and vertebral artery malformations, ect.; 4. Imaging findings in patients with spinal infection, fracture, tumor, tuberculosis, severe deformity, severe osteoporosis,ankylosing spondylitis, Paget's disease,ect.; 5. Patients with severe primary diseases of liver, kidney and other organs as well as the cardiovascular system, hematopoietic system, the digestive system, and with tumor, mental illness, autoimmune disease, diabetes, severe hypertension, orthostatic hypotension, hyperlipidemia,atherosclerosis,migraine diseases, ect.; 6. Patients accompanied with vestibular/otogenic disease,eye diseases, brain diseases,drug induced, ect.; 7. Pregnant or prepare pregnacy within 6-month and lactating women; 8. Received or receiving drug or other treatments in 3-month may be affect the efficacy of determination of intervation; 9. reluctant to join the trials.

Design outcomes

Primary

MeasureTime frame
cervical rang of motion;Symmetry of Joints;Dizziness Handicap Inventory;Activity of daily living scale;

Secondary

MeasureTime frame
numerical rating scale;numerical rating scale;

Countries

China

Contacts

Public ContactHongsheng Zhan
shgsyjs@139.com+86 13918449223

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026